These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 1598667

  • 1. Lung tumour growth delay and normal tissue toxicity induced by three cytotoxic platinum drugs.
    van Rongen E, Kal HB, Kuijpers WC, van Berkel AH.
    Strahlenther Onkol; 1992 May; 168(5):300-7. PubMed ID: 1598667
    [Abstract] [Full Text] [Related]

  • 2. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 3. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
    Hecquet B, Caty A, Fournier C, Lefebvre JL, Adenis L.
    Bull Cancer; 1987 Nov; 74(4):433-6. PubMed ID: 3311237
    [Abstract] [Full Text] [Related]

  • 4. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E, van der Vijgh WJ, Nauta MM, Schlüper HM, Pinedo HM.
    Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
    [Abstract] [Full Text] [Related]

  • 5. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
    Yamaguchi H, Kubota T, Takahara T, Takeuchi T, Furukawa T, Kase S, Josui K, Kodaira S, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1135-41. PubMed ID: 2053772
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 7. Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats.
    Hanada K, Asano K, Nishimura T, Chimata T, Matsuo Y, Tsuchiya M, Ogata H.
    J Pharm Pharmacol; 2008 Mar 30; 60(3):317-22. PubMed ID: 18284811
    [Abstract] [Full Text] [Related]

  • 8. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
    Hasegawa J, Kawamura N, Yamada S, Tsuboi N, Akimoto M.
    Gan To Kagaku Ryoho; 1987 Dec 30; 14(12):3279-83. PubMed ID: 3318705
    [Abstract] [Full Text] [Related]

  • 9. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
    Ohno S, Siddik ZH, Baba H, Stephens LC, Strebel FR, Wondergem J, Khokhar AR, Bull JM.
    Cancer Res; 1991 Jun 01; 51(11):2994-3000. PubMed ID: 2032236
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the platinum analogues in bladder cancer cell lines.
    Powles T, Perry J, Shamash J, Liu W, Oliver T, Joel S.
    Urol Int; 2007 Jun 01; 79(1):67-72. PubMed ID: 17627172
    [Abstract] [Full Text] [Related]

  • 11. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H, Meyer S, Shalet SM, Anderson E, Roberts S, Eden OB.
    Med Pediatr Oncol; 2002 Dec 01; 39(6):573-80. PubMed ID: 12376980
    [Abstract] [Full Text] [Related]

  • 12. [Experimental study on carboplatin toxicity--a comparison with cisplatin].
    Suzuki K, Usami T, Sudoko H, Ohtawara Y, Tajima A, Kawabe K, Aso Y.
    Gan To Kagaku Ryoho; 1988 Jul 01; 15(7):2153-8. PubMed ID: 3293538
    [Abstract] [Full Text] [Related]

  • 13. Cytotoxicity of different platinum (II) analogues to human tumour cell lines in vitro and murine tumour in vivo alone or combined with electroporation.
    Cemazar M, Pipan Z, Grabner S, Bukovec N, Sersa G.
    Anticancer Res; 2006 Jul 01; 26(3A):1997-2002. PubMed ID: 16827135
    [Abstract] [Full Text] [Related]

  • 14. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
    Shalinsky DR, Brekken J, Zou H, Bloom LA, McDermott CD, Zook S, Varki NM, Appelt K.
    Clin Cancer Res; 1999 Jul 01; 5(7):1905-17. PubMed ID: 10430098
    [Abstract] [Full Text] [Related]

  • 15. [Organoplatinum compounds. 1987 update].
    Extra JM, Espie M, Calvo F, Marty M.
    Nouv Rev Fr Hematol (1978); 1988 Jul 01; 30(1-2):123-30. PubMed ID: 3290835
    [Abstract] [Full Text] [Related]

  • 16. [Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
    Ariyoshi Y, Ota K.
    Gan To Kagaku Ryoho; 1989 Apr 01; 16(4 Pt 2-2):1379-85. PubMed ID: 2658826
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of side effects of platinum complexes (CDDP, CBDCA, CHIP) on rat bone marrow.
    Prajda N, Kralovánszky J, Gal F, Kiss F, Kerpel-Fronius S.
    In Vivo; 1989 Apr 01; 3(4):267-70. PubMed ID: 2519864
    [Abstract] [Full Text] [Related]

  • 18. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N, Pape H, Schnabel T, Wurm R, Bannach B, Fürst G, Schmitt G.
    Strahlenther Onkol; 1989 Sep 01; 165(9):647-51. PubMed ID: 2678546
    [Abstract] [Full Text] [Related]

  • 19. [Development of carboplatin].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1990 Sep 01; 17(9):1949-58. PubMed ID: 2203318
    [Abstract] [Full Text] [Related]

  • 20. Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase.
    Deng HB, Adikari M, Parekh HK, Simpkins H.
    Cancer Chemother Pharmacol; 2004 Oct 01; 54(4):301-7. PubMed ID: 15138708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.